TFC Financial Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66K | Buy |
34
+6
| +21% | +$469 | ﹤0.01% | 481 |
|
|
2025
Q1 | $2.03K | Buy |
28
+3
| +12% | +$218 | ﹤0.01% | 489 |
|
|
2024
Q4 | $1.85K | Buy |
25
+7
| +39% | +$518 | ﹤0.01% | 510 |
|
|
2024
Q3 | $1.19K | Sell |
18
-25
| -58% | -$1.65K | ﹤0.01% | 566 |
|
|
2024
Q2 | $3.97K | Buy |
43
+5
| +13% | +$462 | ﹤0.01% | 409 |
|
|
2024
Q1 | $3.63K | Buy |
38
+3
| +9% | +$287 | ﹤0.01% | 411 |
|
|
2023
Q4 | $2.67K | Sell |
35
-8
| -19% | -$610 | ﹤0.01% | 426 |
|
|
2023
Q3 | $2.98K | Sell |
43
-1
| -2% | -$69 | ﹤0.01% | 427 |
|
|
2023
Q2 | $4.15K | Sell |
44
-195
| -82% | -$18.4K | ﹤0.01% | 384 |
|
|
2023
Q1 | $19.8K | Buy |
239
+213
| +819% | +$17.6K | 0.01% | 316 |
|
|
2022
Q4 | $1.94K | Buy |
26
+8
| +44% | +$597 | ﹤0.01% | 404 |
|
|
2022
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 470 |
|
|
2022
Q2 | $2K | Hold |
18
| – | – | ﹤0.01% | 400 |
|
|
2022
Q1 | $2K | Hold |
18
| – | – | ﹤0.01% | 416 |
|
|
2021
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 464 |
|
|
2021
Q3 | $2K | Hold |
18
| – | – | ﹤0.01% | 452 |
|
|
2021
Q2 | $2K | Hold |
18
| – | – | ﹤0.01% | 444 |
|
|
2021
Q1 | $2K | Hold |
18
| – | – | ﹤0.01% | 434 |
|
|
2020
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 427 |
|
|
2020
Q3 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 455 |
|